Gene · 54795
Papers1,538
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,538
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Protection of the human aortic valve interstitial cells against radiation-induced remodeling by repression of the TRPM4 channel. | Am J Physiol Cell Physiol | 2025 | 41021696 | PubTator, text mining | PubMed |
| Construction of a prognostic model for hepatocellular carcinoma based on necrosis by sodium overload-related genes and identification of ANKRD13B as a new prognostic marker. | Funct Integr Genomics | 2025 | 40956482 | PubTator, text mining | PubMed |
| Targeting TRPV6/CXCR4 complexes prevents castration-resistant prostate cancer metastasis to the bone. | Signal Transduct Target Ther | 2025 | 40908300 | PubTator, text mining | PubMed |
| Mepolizumab alters gene regulatory networks of nasal airway type-2 and epithelial inflammation in urban children with asthma. | Nat Commun | 2025 | 40897727 | PubTator, text mining | PubMed |
| Multigenerational TRPM4 variant presenting with fetal atrioventricular block and atrial arrhythmias. | HeartRhythm Case Rep | 2025 | 40896669 | PubTator, text mining | PubMed |
| Identification and validation of prognostic genes associated with mitochondrial nuclear genes in gastric cancer. | Clin Exp Med | 2025 | 40886211 | PubTator, text mining | PubMed |
| Comprehensive Insights Into the Role of TRPM4 in Pan-Cancer Progression and Immune Regulation. | Immunotargets Ther | 2025 | 40860345 | PubTator, text mining | PubMed |
| Cinobufagin overcomes bortezomib resistance in multiple myeloma strains by targeting SEC62/TRPM4-mediated NECSO. | Phytomedicine | 2025 | 40839992 | PubTator, text mining | PubMed |
| The Cerebral Lymphatic System: Function, Controversies, and Therapeutic Approaches for Central Nervous System Diseases. | Cell Mol Neurobiol | 2025 | 40828342 | PubTator, text mining | PubMed |
| Multidimensional pan cancer analysis of the sodium induced cell death gene TRPM4. | Sci Rep | 2025 | 40804073 | PubTator, text mining | PubMed |
| Ion channels in respiratory rhythm generation and sensorimotor integration. | Neuron | 2025 | 40752487 | PubTator, text mining | PubMed |
| Reduction of the Ca2+ permeability of ligand-gated ion channels as a strategy against excitotoxicity. | Front Cell Neurosci | 2025 | 40740969 | PubTator, text mining | PubMed |
| Postzygotic Gain-of-Function Variant in TRPM4 and Inflammatory Linear Verrucous Epidermal Nevus. | JAMA Dermatol | 2025 | 40699612 | PubTator, text mining | PubMed |
| Interpretable machine learning driven biomarker identification and validation for prostate cancer. | Transl Androl Urol | 2025 | 40687654 | PubTator, text mining | PubMed |
| Safety and efficacy of glibenclamide on functional outcomes in ischemic and hemorrhagic stroke: a systematic review and meta-analysis of randomized clinical trials. | Front Neurol | 2025 | 40656980 | PubTator, text mining | PubMed |
| SUR1-TRPM4 Regulates Aquaporin-4 Subcellular Localization by Astrocytic Endfeet Calcium Signals Following Status Epilepticus. | Glia | 2025 | 40631759 | PubTator, text mining | PubMed |
| The Efficacy and Safety of Glibenclamide in Improving Cerebral Edema and Neurological Outcomes in Stroke: a GRADE-Evaluated Systematic Review and Meta-analysis with Subgroup Analysis. | Neurocrit Care | 2025 | 40629214 | PubTator, text mining | PubMed |
| The impact of sulfonylureas on survival in patients with severe ischemic stroke and type 2 diabetes: A retrospective study based on the MIMIC-IV database. | J Clin Neurosci | 2025 | 40618539 | PubTator, text mining | PubMed |
| The nonsteroidal anti-inflammatory drug meclofenamate mitigates kainic acid-induced seizures via TRPM4 inhibition. | Brain Commun | 2025 | 40574972 | PubTator, text mining | PubMed |
| The role of transient receptor potential melastatin channels in compressive force-induced contraction of primary cardiac pericytes. | Physiol Rep | 2025 | 40526043 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54795/papers?page=5